Monday, April 25, 2016

BRIEF-Fibrocell receives orphan drug designation for FCX-013

* Sats receives orphan drug designation from the FDA for for

FCX-013 for the treatment of localized scleroderma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)